Anti-p27Kip1 (Mitotic Inhibitor/Suppressor Protein) Monoclonal Antibody (Clone: KIP1/769)-CF488, Clone: [KIP1/769], Mouse

Artikelnummer: ABI-36-2027
Artikelname: Anti-p27Kip1 (Mitotic Inhibitor/Suppressor Protein) Monoclonal Antibody (Clone: KIP1/769)-CF488, Clone: [KIP1/769], Mouse
Artikelnummer: ABI-36-2027
Hersteller Artikelnummer: 36-2027
Alternativnummer: ABI-36-2027-0.5AT100MLATUG/ML
Hersteller: Abeomics
Wirt: Mouse
Kategorie: Antikörper
Applikation: FACS, IF
Spezies Reaktivität: Human, Mouse, Rat
Immunogen: Recombinant human KIP1 protein
Konjugation: CF488
Alternative Synonym: CDKN1B, CDKN4, Cyclin Dependent Kinase Inhibitor 1B, Cyclin-dependent kinase inhibitor p27 Kip1, KIP1, MEN1B, MEN4
This MAb recognizes a 27kDa protein, identified as the p27Kip1, a cell cycle regulatory mitotic inhibitor. It is highly specific and shows no cross-reaction with other related mitotic inhibitors. In Western blotting of cell lysates from 7 human breast cancer cell lines (ZR75-1, ZR75-30, MCF-7, MDAMB453, T47D, CAL51, 734B), the antibody labels a single band corresponding to p27Kip1. It functions as a negative regulator of G1 progression and has been proposed to function as a possible mediator of TGF-alpha induced G1 arrest. p27Kip1 is a candidate tumor suppressor gene. Reportedly, low p27 expression has been associated with unfavorable prognosis in renal cell carcinoma, colon carcinoma, breast carcinomas, non-small-cell lung carcinoma, hepatocellular carcinoma, multiple myeloma, and lymph node metastases in papillary carcinoma of the thyroid, as well as a more aggressive phenotype in carcinoma of the cervix.
Klonalität: Monoclonal
Klon-Bezeichnung: [KIP1/769]
NCBI: 1027
UniProt: P46527
Application Verdünnung: Flow Cytometry (5ul per test per one million cells or 5ul per 100ul of whole blood),Immunofluorescence (1:50-1:100),